THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS

05-5-2021 Blog Posts

Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver Relief for American Patients During a pair of hearings this week in the U.S. House Energy & Commerce Committee Subcommittee on Health and House Education & Labor Committee Subcommittee on Health, Employment, Labor, and Pensions, lawmakers from both parties emphasized the urgent need […]

BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA

05-5-2021 Blog Posts

Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On Massive Taxpayer-Funded Vaccine Profits New first quarter earnings reports from Big Pharma giants Pfizer, AbbVie and AstraZeneca topped Wall Street analysts’ expectations. Pfizer, in particular, smashed forecasts and raised its profit guidance for the year. The company’s big time earnings were driven, in large […]

BIG PHARMA EARNINGS WATCH: SANOFI, MERCK, BRISTOL-MYERS SQUIBB, AMGEN & GLAXOSMITHKLINE

05-4-2021 Blog Posts

Brand Name Drug Makers Boosting Profits, Sales After Engaging In Pandemic Price Hikes Another round of first quarter earnings reports from brand name drug makers Sanofi, Merck, Bristol-Myers Squibb (BMS), Amgen, and GlaxoSmithKline (GSK) showcase how Big Pharma continues to bank expectation-beating profits and rising sales against a backdrop of continued price hikes — even […]

BIG PHARMA WATCH: GAO REPORT FINDS U.S. CONSUMERS PAY DOUBLE TO QUADRUPLE FOR RX DRUGS

04-29-2021 Blog Posts

Study Finds Americans Face Much Higher Drug Prices Than Patients In Other Countries A new report from the U.S. Government Accountability Office (GAO) found that net prices for prescription drugs in the United States for 20 selected brand-name products were two to four times higher than the prices paid in Canada, Australia and France. The […]

BIG PHARMA EARNINGS WATCH: NOVARTIS, ELI LILLY & ROCHE

04-29-2021 Blog Posts

Trio of Big Pharma Firms Bank Q1 Profits Driven By Price Hikes New first quarter earnings reports from brand name drug makers Novartis, Eli Lilly, and Roche demonstrate yet again that price-hikes and anti-competitive behavior continue to drive big time profits for Big Pharma companies. Novartis Net sales for the drug maker hit $12.4 billion […]

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

04-20-2021 Blog Posts

Drug Company Banks Expectation-Busting Profits for Q1 While Continuing to Hike Rx Prices During Pandemic Johnson & Johnson kicked off the first quarterly earnings season of the year for Big Pharma Tuesday by reporting sales and revenue beats driven by price-hiking and anti-competitive behavior on prescription drugs. Johnson & Johnson Johnson & Johnson beat Wall […]

ICYMI: AMERICANS NEED RELIEF FROM BIG PHARMA’S OUT-OF-CONTROL PRESCRIPTION PRICES

04-19-2021 Blog Posts

Americans Need Relief from Big Pharma’s Out-of-Control Prescription Prices Morning Consult Lauren Aronson April 19, 2021 https://morningconsult.com/opinions/americans-need-relief-from-big-pharmas-out-of-control-prescription-prices/   Earlier this month, the principal trade group representing Big Pharma launched a new branding campaign touting drug companies’ role during the pandemic. While we can all be thankful for the vaccines and treatments that save lives and support a […]

DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR AMERICA’S CANCER PATIENTS

04-15-2021 Blog Posts

Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on Oncology Medications THE PROBLEM: A CRISIS OF AFFORDABILITY The out-of-control prices set by Big Pharma on prescription drugs used to treat cancer have created a crisis of affordability — and placed breakthrough treatments out-of-reach for too many American patients. Patients and families should never […]

SECOND OPINION: DEBUNKING BIG PHARMA’S NEW BRANDING CAMPAIGN

04-15-2021 Blog Posts

PhRMA Proposals Fail to Lower Rx Prices and Instead Benefit Drug Companies and Shift Costs — While Ad Campaign Seeks to Divert Attention from Egregious Practices This week, the principal trade group for Big Pharma, the Pharmaceutical Research and Manufacturers of America (PhRMA), launched a new seven-figure ad campaign seeking to bolster the industry’s image […]

THEY SAID IT! BIG PHARMA’S PRICE HIKES, PATENT THICKETS AND ADVERTISING SPENDING TAKE CENTER STAGE DURING SENATE HEARING

03-23-2021 Blog Posts

Lawmakers Make Bipartisan Commitment to Lowering Drug Prices, Holding Drug Companies Accountable During a hearing on prescription drug prices on Tuesday before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) Subcommittee on Primary Health and Retirement Security, lawmakers on both sides of the aisle expressed a commitment to working together to lower drug prices […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.